News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current VBS market cap is 6.12M. The company's latest EPS is AUD -0.0648 and P/E is -1.70.
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 9k | 50k | 1.02M | 1.3M | 1.3M |
| Operating Income | -2.37M | -2.67M | -2.79M | -3.3M | -3.3M |
| Net Income | -1.6M | -3M | -3.86M | -3.99M | -3.45M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 194k | 3M | 6.98M | 3.94M | 4.63M |
| Total Liabilities | 3.92M | 8.64M | 8.87M | 7.47M | 1.11M |
| Total Equity | -3.73M | -5.65M | -1.89M | -3.53M | 3.52M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -1.04M | -3M | -3.26M | -4.44M | -2.35M |
| Investing | N/A | N/A | N/A | -21k | -17k |
| Financing | 1.04M | 5.64M | 6.35M | -35k | 4.04M |
| Market Cap | 6.12M |
| Price to Earnings Ratio | -1.70 |
| Price to Sales Ratio | 4.51 |
| Price to Cash Ratio | 1.98 |
| Price to Book Ratio | 1.66 |
| Dividend Yield | - |
| Shares Outstanding | 53.21M |
| Average Volume (1 week) | 8.54k |
| Average Volume (1 Month) | 203.65k |
| 52 Week Change | -72.29% |
| 52 Week High | 0.50 |
| 52 Week Low | 0.115 |
| Spread (Intraday) | 0.03 (22.22%) |
| Company Name | Vectus Biosystems Limited |
| Address |
3-11 primrose avenue sydney, new south wales 2018 |
| Website | https://www.vectusbiosystems.com.au |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
